The Future of Medicaid Managed Care: What States & National Payers Need to Prepare For

Medicaid managed care is entering one of its most volatile financial and regulatory cycles in recent history. After years of enrollment growth and relative margin stability, the combined effects of post–public health emergency redeterminations, new federal policy changes, and state fiscal pressures are reshaping the market at speed. For managed care organizations (MCOs), the next three years will test underwriting discipline, operational maturity, and contract agility.

At the same time, states are under mounting pressure to balance budgets while complying with new federal eligibility, financing, and oversight requirements. Expansion states, many of which built advanced managed care infrastructure over the last decade, are now a proving ground for how policy shifts will play out nationally.

Review the national Medicaid trends, regulatory inflection points, and managed care strategies that will define performance through 2026 and beyond.

Financial Headwinds & Risk Mix Deterioration

The most immediate challenge is financial. Medicaid EBITDA declined sharply from $14 billion in 2023 to $3 billion in 2024, largely driven by adverse selection following the expiration of the public health emergency continuous coverage provisions.¹ As redeterminations progressed, healthier members disproportionately exited the program, compressing margins and degrading the risk mix.

The outlook is more sobering. Between 2027 and 2028, overall Medicaid enrollment is projected to decline by nine to ten million members, with MCOs losing approximately seven million members.¹ Compounding the issue, rate adjustments typically lag experience by 18 to 24 months. As a result, EBITDA across the Medicaid segment is expected to fall into negative territory in 2025 and 2026 and could reach approximately negative $7 billion by 2028 before modest stabilization occurs in 2029.¹

For national payers, this creates a two-track challenge:

1. Managing margin compression in expansion-heavy portfolios, where enrollment volatility is highest.
2. Preparing for rate revalidation cycles that may not fully capture near-term acuity shifts.

Advocates and state policymakers are identifying enrollment oversight, network adequacy, benefit design, and MCO accountability as top Medicaid managed care priorities for 2026.² These priorities reflect mounting fiscal and operational strain at the state level. Federal Medicaid spending reductions under the 2025 reconciliation law are estimated at $911 billion over ten years.³ Although many financing changes take effect in 2027 or later, restrictions on provider taxes are already limiting states’ fiscal flexibility.³ Historically, provider taxes have buffered downturns. That tool is now constrained.

For MCOs, financial strategy must extend beyond actuarial modeling. Medical loss ratio (MLR) scrutiny is intensifying, and some stakeholders are advocating for stronger minimum thresholds and repayment provisions in contracts.² Plans that treat MLR management as purely retrospective risk missing opportunities to rebalance cost structures in real time.

Eligibility Reform & Operational Strain

Eligibility policy is the second major inflection point. States must meet new requirements under the 2025 reconciliation law, including work requirements for expansion adults effective January 1, 2027 and more frequent eligibility redeterminations.³ Over half of the projected 7.5 million increase in the uninsured population tied to Medicaid changes is attributed to new work requirements for expansion enrollees.³

Operationalizing these changes is not trivial. States must upgrade eligibility systems, expand data-sharing infrastructure, and redesign renewal workflows often before detailed federal guidance is issued.³ The compressed timeline increases the likelihood of mid-course corrections and cost overruns.

Medicaid enrollment, outreach, benefits, network adequacy, and future state planning are top managed care issues in 2026.² For enrollment specifically, advocates are urging states to:²

• Update transaction systems to capture detailed disenrollment reasons
• Provide MCOs with monthly termination files
• Allow plans to assist with applications and redeterminations
• Require proactive outreach to members at risk of losing coverage

For MCOs, eligibility reform creates both risk and opportunity. Risk, because procedural terminations and six-month redeterminations for expansion adults could accelerate membership churn. Opportunity, because states increasingly expect plans to play a formal role in renewal outreach and data verification.

Plans with integrated enrollment analytics, community partnerships, and multilingual outreach infrastructure will be positioned to mitigate avoidable disenrollment. Those without these capabilities may see avoidable membership loss compound financial headwinds.

Benefits, Optional Services & the HCBS Pressure Point

As fiscal pressure intensifies, optional benefits are often first in line for review. KFF notes that some states have already restricted GLP-1 coverage for obesity treatment and that governors’ budgets have proposed limits on dental and home care services.³ Although mandatory drug coverage remains intact, statutory flexibility allows states to exclude certain weight-loss medications.³

Families USA anticipates additional scrutiny of home- and community-based services (HCBS), behavioral health, and reproductive health services as states confront funding gaps.² Importantly, Medicaid funding reductions phase in over time—provider tax reductions in expansion states do not begin until fiscal year 2028—giving states a planning window.²

Managed care contracts will be a primary vehicle for mediating benefit changes. Advocates are encouraging:²

• Use of “in lieu of services” authority to address health-related social needs
• Quality metrics tied to HCBS
• Clarity around freedom-of-choice protections for reproductive health services
• Explicit quality improvement investments in nursing facilities

For national payers, expansion states that previously used Section 1115 waivers to broaden benefits may reassess those initiatives. The current administration has rescinded prior guidance on health-related social needs waivers and signaled a more restrictive approach to certain 1115 authorities.³ Additionally, the reconciliation law requires the CMS Chief Actuary to certify that waivers do not increase federal expenditures relative to baseline.³

Plans operating in multiple states should expect variability in waiver direction and benefit scope. Portfolio diversification will not eliminate exposure; it will redistribute it.

Network Adequacy, Provider Payment & Workforce Instability

Network adequacy compliance will become more complex as reimbursement pressure grows. By July 2027, MCOs must meet updated federal network adequacy standards.² At the same time, restrictions on provider taxes and broader state budget constraints may limit states’ ability to raise rates.³

States are being encouraged to:²

• Seek approval for state-directed payments (SDPs) in high-risk service areas
• Link value-based SDPs to quality performance
• Reduce admin burdens like credentialing delays and prior authorization complexity
• Reinforce new prior authorization decision time frames

The tension is payment restraint to manage budgets versus payment increases to sustain provider participation. In markets with fragile rural hospital systems or safety-net providers, even modest reimbursement compression could lead to service reductions or closures.³

Workforce dynamics add another layer of uncertainty. Immigration policy shifts and heightened enforcement have already affected labor participation in some communities. KFF survey data indicates that 13% of immigrants have avoided going to work since January 2025 due to immigration concerns, rising to 40% among those likely to be undocumented.³ More than one in four long-term care workers are immigrants, and immigrants account for over one in four physicians in US hospitals.³

For Medicaid MCOs with significant LTSS exposure, workforce contraction intersects directly with access standards and quality metrics. Contractual network compliance will not insulate plans from real-world staffing shortages.

Political Cycles & Strategic Timing

The policy environment through 2026 is also shaped by election cycles. Thirty-nine gubernatorial elections are scheduled, and federal mid-term elections could alter congressional dynamics.³ While major federal Medicaid legislation in 2026 is considered unlikely, regulatory guidance, waiver decisions, and administrative priorities remain fluid.³

States must make operational investments now to meet 2027 deadlines, even as leadership changes may shift policy emphasis. For MCOs, procurement cycles during this period will likely incorporate heightened oversight expectations, more explicit performance benchmarks, and tighter financial guardrails.

Families USA highlights increased state use of sanctions, public reporting of MLR data, and corrective action plans as accountability tools that may gain traction.² Plans bidding in upcoming procurements should anticipate expanded reporting requirements and more detailed expectations around outreach, network monitoring, and quality improvement.

Implications for National Payers

National Medicaid managed care organizations should prepare for four concurrent realities:

1. Sustained margin volatility through at least 2028. Risk mix deterioration and rate lag will continue to pressure EBITDA.¹
2. Operational complexity in eligibility and outreach. Work requirements and six-month redeterminations for expansion adults require infrastructure that bridges state systems and plan operations.^3,2
3. Benefit and network variability across states. Fiscal stress, waiver recalibration, and differing political leadership will drive heterogeneous benefit design and provider payment strategies.^3,2
4. Heightened oversight and contractual specificity. From MLR thresholds to prior authorization turnaround times, states are likely to codify more granular performance expectations.²

Expansion states, which are historically leaders in managed care innovation, may again serve as laboratories. Their responses to enrollment loss, HCBS prioritization, and value-based SDPs will inform replication elsewhere.

For organizations with national footprints, this period calls for disciplined portfolio review, sharper acuity forecasting, and operational investments aligned with enrollment retention and network resilience. Medicaid managed care will remain central to state coverage strategy; 75% of beneficiaries are enrolled in comprehensive MCOs nationally.² The delivery system is not retreating from managed care; it is demanding more from it.

Medicaid managed care is entering a stretch where enrollment volatility, risk mix deterioration, financing constraints, and tighter oversight converge at once. To outperform through 2026 and beyond, plans should align actuarial strategy with operational execution, reducing avoidable disenrollment, reinforcing provider networks under rate pressure, strengthening compliance infrastructure, and preparing for more prescriptive contract terms.

Clearlink partners with MCOs to translate regulatory change and fiscal pressure into disciplined clinical and operational performance. If you are recalibrating your Medicaid strategy for the next procurement cycle, contact us for experienced support.

Sources:

1. What to Expect in US Healthcare in 2026 & Beyond: Medicaid, McKinsey & Company
2. Medicaid Managed Care: Top Issues for Advocates in 2026, Families USA
3. Medicaid: What to Watch in 2026, KFF